3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-
概要：3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-（CAS 75059-67-5）是一种化学化合物，分子式为C24H26O8，分子量为442.16 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务，支持克级到吨级规格。
[(1R,3R,5S,6S,9R,18S)-6-hydroxy-18-(methoxymethyl)-1,5-dimethyl-7-methylidene-11,16-dioxo-13,17-dioxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),12(19),14-trien-3-yl] acetate
又称：3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-, (1S,6bR,9S,9aS,11R,11bR)-9-Hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylidene-3,6-dioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h][2]benzopyran-11-yl acetate, 9-Hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylidene-3,6-dioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h][2]benzopyran-11-yl acetate
| 分子式 | C24H26O8 |
|---|---|
| 分子量 | 442.16 g/mol |
| LogP | 1.3 |
| 拓扑极性表面积 | 112.0 Ų |
| 氢键供体数 | 1 |
| 氢键受体数 | 8 |
| 可旋转键数 | 4 |
| 精确质量 | 442.16278 |
| 重原子数 | 32 |
| 复杂度 | 952.0 |
化学标识符
| CAS 编号 | 75059-67-5 |
|---|---|
| SMILES | CC(=O)O[C@@H]1C[C@]2([C@@H](CC(=C)[C@@H]2O)C3=C1[C@]4([C@H](OC(=O)C5=COC(=C54)C3=O)COC)C)C |
| InChIKey | XGGHYTIKMUVLMA-BRHWEAGTSA-N |
产品概述
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-（CAS 75059-67-5），分子式为C24H26O8，分子量为442.16 g/mol。IUPAC名：[(1R,3R,5S,6S,9R,18S)-6-hydroxy-18-(methoxymethyl)-1,5-dimethyl-7-methylidene-11,16-dioxo-13,17-dioxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),12(19),14-trien-3-yl] acetate。
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-化学性质概览
属性洞察：3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的XLogP值为1.3，表明具有中等亲脂性，在水溶性和膜透过性之间取得平衡。 TPSA为112.0 Ų，处于中等极性范围，在透过性和溶解性之间取得平衡。 根据Lipinski五规则，3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-有1个氢键供体和8个氢键受体，均在类药范围内，提示具有较好的口服生物利用度潜力。
常见问题
常见问题
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的CAS号是多少？
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的CAS号为75059-67-5。
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的分子式是什么？
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的分子式为C24H26O8。
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的分子量是多少？
3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的分子量为442.16 g/mol。
在哪里可以购买3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-？
您可以直接向科弘生物询价3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-的定制合成服务？
是的，科弘生物提供3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-及相关化合物的定制合成服务。请联系我们并告知您的具体需求，包括数量、纯度和交期。